Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times BPC 157 Banned: Key Facts on the Latest FDA Decision FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling